Avadel Pharmaceuticals (AVDL) News Today → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free AVDL Stock Alerts $15.13 -0.12 (-0.79%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 10 at 1:20 AM | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Rating of "Buy" from AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has been assigned a consensus rating of "Buy" from the six brokerages that are presently covering the stock, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-montJune 7 at 11:23 PM | marketbeat.comRTW Investments LP Has $98.11 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)RTW Investments LP lowered its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 2.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,947,918 shares of the company's stock after selling 188,497June 5, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Trading Down 3%Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Down 3%May 31, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Up 18.3% in MayAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 5,680,000 shares, a growth of 18.3% from the April 30th total of 4,800,000 shares. Based on an average daily trading volume, of 1,250,000 shares, the days-to-cover ratio is presently 4.5 days.May 30, 2024 | globenewswire.comAvadel Pharmaceuticals to Present at Upcoming Investor ConferencesMay 22, 2024 | finanznachrichten.deAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Shares New LUMRYZ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024May 22, 2024 | finance.yahoo.comAvadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024May 22, 2024 | globenewswire.comAvadel Pharmaceuticals Shares New LUMRYZ™ (sodium oxybate) For Extended-release Oral Suspension (CIII) Data at SLEEP 2024May 21, 2024 | globenewswire.comAvadel Pharmaceuticals Appoints Naseem Amin, M.D. to its Board of DirectorsMay 20, 2024 | marketbeat.comBrandes Investment Partners LP Has $21.66 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Brandes Investment Partners LP boosted its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 5.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,533,614 shares of thMay 16, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Consensus Rating of "Buy" from AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has received a consensus rating of "Buy" from the six research firms that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month price target among broMay 13, 2024 | msn.comAvadel gains for a second day as analysts see it prevailing in case vs Jazz/FDAMay 11, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Sees Significant Decrease in Short InterestAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totalling 4,800,000 shares, a decrease of 54.8% from the April 15th total of 10,610,000 shares. Based on an average trading volume of 1,250,000 shares, the days-to-cover ratio is currently 3.8 days.May 10, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Trading 5.2% Higher on Analyst UpgradeAvadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Up 5.2% on Analyst UpgradeMay 10, 2024 | marketbeat.comQ4 2024 EPS Estimates for Avadel Pharmaceuticals plc (NASDAQ:AVDL) Reduced by Leerink PartnrsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Investment analysts at Leerink Partnrs decreased their Q4 2024 earnings per share (EPS) estimates for shares of Avadel Pharmaceuticals in a report issued on Wednesday, May 8th. Leerink Partnrs analyst M. Goodman now expects that the companyMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed for Avadel Pharmaceuticals Amidst Strong Growth Potential and Market ExpansionMay 9, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Price Target Raised to $27.00HC Wainwright lifted their target price on shares of Avadel Pharmaceuticals from $25.00 to $27.00 and gave the company a "buy" rating in a research note on Thursday.May 9, 2024 | finance.yahoo.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Issues Earnings ResultsAvadel Pharmaceuticals (NASDAQ:AVDL - Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.25) by ($0.05). The business had revenue of $27.18 million for the quarter, compared to analyst estimates of $25.89 million. The company's revenue for the quarter was up 2617.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.48) EPS.May 9, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 7.3% on Disappointing EarningsAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 7.3% on Disappointing EarningsMay 8, 2024 | msn.comAvadel Pharmaceuticals GAAP EPS of -$0.30 misses by $0.29, revenue of $27.18M beats by $1.28MMay 8, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $18.18Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Down to $18.18May 8, 2024 | investorplace.comAVDL Stock Earnings: Avadel Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024May 8, 2024 | finanznachrichten.deAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 8, 2024 | finance.yahoo.comAvadel Pharmaceuticals Reports First Quarter 2024 Earnings: Revenue Surpasses Estimates but Net ...May 8, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $22.00 price objective on shares of Avadel Pharmaceuticals in a research note on Wednesday.May 8, 2024 | globenewswire.comAvadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 2, 2024 | marketbeat.comAvadel Pharmaceuticals (AVDL) to Release Quarterly Earnings on WednesdayAvadel Pharmaceuticals (NASDAQ:AVDL) will be releasing earnings before the market opens on Wednesday, May 8, Zacks reports.May 1, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 1-Year High at $18.97Avadel Pharmaceuticals (NASDAQ:AVDL) Sets New 12-Month High at $18.97May 1, 2024 | globenewswire.comAvadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8April 29, 2024 | finance.yahoo.comWall Street Analysts Predict a 28.58% Upside in Avadel (AVDL): Here's What You Should KnowApril 27, 2024 | marketbeat.comVivo Capital LLC Sells 124,329 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Vivo Capital LLC reduced its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 3.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,972,099 shares of the company's stock aftApril 25, 2024 | msn.comEuropean Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday TradingApril 21, 2024 | money.usnews.comAvadel Pharmaceuticals plcApril 18, 2024 | marketbeat.com106,475 Shares in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Purchased by Investors Asset Management of Georgia Inc. GA ADVInvestors Asset Management of Georgia Inc. GA ADV acquired a new position in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 106,April 17, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Down 3.4% Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Down 3.4%April 16, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Hits New 1-Year High at $18.08Avadel Pharmaceuticals (NASDAQ:AVDL) Reaches New 12-Month High at $18.08April 16, 2024 | marketbeat.comAvadel Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:AVDL)Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) saw unusually large options trading activity on Tuesday. Stock traders purchased 4,733 call options on the company. This represents an increase of approximately 92% compared to the typical volume of 2,463 call options.April 16, 2024 | finance.yahoo.comAvadel Pharmaceuticals plc (AVDL)April 15, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Trading 5.9% Higher Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Up 5.9%April 11, 2024 | marketbeat.comTraders Buy Large Volume of Put Options on Avadel Pharmaceuticals (NASDAQ:AVDL)Avadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) saw some unusual options trading activity on Thursday. Traders bought 3,934 put options on the company. This is an increase of 73% compared to the average daily volume of 2,276 put options.April 11, 2024 | finance.yahoo.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Is Expected To Breakeven In The Near FutureApril 9, 2024 | marketbeat.comAvadel Pharmaceuticals' (AVDL) "Buy" Rating Reiterated at Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and issued a $22.00 price objective on shares of Avadel Pharmaceuticals in a research report on Tuesday.April 4, 2024 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Share Price Passes Above 200-Day Moving Average of $13.24Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Crosses Above 200-Day Moving Average of $13.24April 2, 2024 | seekingalpha.comAvadel Pharmaceuticals: A Deep Dive Into Lumryz's Once-Nightly RevolutionApril 1, 2024 | globenewswire.comAvadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare ConferenceMarch 17, 2024 | finance.yahoo.comAVDL Apr 2024 15.000 callMarch 16, 2024 | finance.yahoo.comAVDL Apr 2024 25.000 callMarch 16, 2024 | finance.yahoo.comAVDL Apr 2024 10.000 putMarch 15, 2024 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Sees Significant Growth in Short InterestAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) was the recipient of a large increase in short interest in February. As of February 29th, there was short interest totalling 10,740,000 shares, an increase of 21.2% from the February 14th total of 8,860,000 shares. Based on an average daily volume of 1,270,000 shares, the days-to-cover ratio is currently 8.5 days. Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report AVDL Media Mentions By Week AVDL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVDL News Sentiment▼0.810.77▲Average Medical News Sentiment AVDL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVDL Articles This Week▼32▲AVDL Articles Average Week Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: COLL News Today BCYC News Today IMUX News Today IONS News Today CYTK News Today SMMT News Today OGN News Today MDGL News Today NUVL News Today BBIO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVDL) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredYou won't believe what Citigroup just did to it's depositorsThe FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored